Hoffmann T, Oelzner P, Teichgräber U, Franz M, Gaßler N, Kroegel C, Wolf G, Pfeil A (2022) Diagnosing lung involvement in inflammatory rheumatic diseases-Where do we currently stand? Front Med (Lausanne) 9:1101448. https://doi.org/10.3389/fmed.2022.1101448

Article  PubMed  Google Scholar 

Hoffmann T, Oelzner P, Busch M, Franz M, Teichgräber U, Kroegel C, Schulze PC, Wolf G, Pfeil A (2022) Organ manifestation and systematic organ screening at the onset of inflammatory rheumatic diseases. Diagnostics 12(1). https://doi.org/10.3390/diagnostics12010067

Wijsenbeek M, Cottin V (2020) Spectrum of fibrotic lung diseases. N Engl J Med 383(10):958–968. https://doi.org/10.1056/NEJMra2005230

Article  CAS  PubMed  Google Scholar 

Joy GM, Arbiv OA, Wong CK, Lok SD, Adderley NA, Dobosz KM, Johannson KA, Ryerson CJ (2023) Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis. Eur Respir Rev 32(167). https://doi.org/10.1183/16000617.0210-2022

Hoffmann T, Oelzner P, Franz M, Teichgräber U, Renz D, Förster M, Böttcher J, Kroegel C, Schulze PC, Wolf G, Pfeil A (2022) Assessing the diagnostic value of a potential screening tool for detecting early interstitial lung disease at the onset of inflammatory rheumatic diseases. Arthritis Res Ther 24(1):107. https://doi.org/10.1186/s13075-022-02786-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Müller-Ladner U, Distler O, Iannone F, Pellerito R, Pileckyte M, Miniati I, Ananieva L, Gurman AB, Damjanov N, Mueller A, Valentini G, Riemekasten G, Tikly M, Hummers L, Henriques MJ, Caramaschi P, Scheja A, Rozman B, Ton E, Kumánovics G, Coleiro B, Feierl E, Szucs G, Von Mühlen CA, Riccieri V, Novak S, Chizzolini C, Kotulska A, Denton C, Coelho PC, Kötter I, Simsek I, Hachulla E, Seibold JR, Rednic S, Stork J, Morovic-Vergles J, Walker UA (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR scleroderma trials and research (EUSTAR) database. Ann Rheum Dis 69(10):1809–1815. https://doi.org/10.1136/ard.2009.114264

Article  PubMed  Google Scholar 

Pecher AC, Hensen L, Klein R, Schairer R, Lutz K, Atar D, Seitz C, Stanger A, Schneider J, Braun C, Schmidt M, Horger M, Bornemann A, Faul C, Bethge W, Henes J, Lengerke C (2023) CD19-Targeting CAR T cells for myositis and interstitial lung disease associated with antisynthetase syndrome. JAMA 329(24):2154–2162. https://doi.org/10.1001/jama.2023.8753

Article  CAS  PubMed  PubMed Central  Google Scholar 

Müller F, Boeltz S, Knitza J, Aigner M, Völkl S, Kharboutli S, Reimann H, Taubmann J, Kretschmann S, Rösler W, Manger B, Wacker J, Mougiakakos D, Jabari S, Schröder R, Uder M, Roemer F, Krönke G, Mackensen A, Schett G (2023) CD19-targeted CAR T cells in refractory antisynthetase syndrome. Lancet 401(10379):815–818. https://doi.org/10.1016/s0140-6736(23)00023-5

Article  CAS  PubMed  Google Scholar 

Robles-Perez A, Dorca J, Castellví I, Nolla JM, Molina-Molina M, Narváez J (2020) Rituximab effect in severe progressive connective tissue disease-related lung disease: preliminary data. Rheumatol Int 40(5):719–726. https://doi.org/10.1007/s00296-020-04545-0

Article  CAS  PubMed  Google Scholar 

Suzuki K, Akiyama M, Shimanuki K, Kaneko Y (2025) Radiological extent predicts prognosis and relapse after acute exacerbation of interstitial lung disease in patients with rheumatoid arthritis: KEIO-RA-cohort. Rheumatol Int 45(4):92. https://doi.org/10.1007/s00296-025-05854-y

Article  PubMed  Google Scholar 

Hoffmann-Vold A-M, Maher TM, Philpot EE, Ashrafzadeh A, Barake R, Barsotti S, Bruni C, Carducci P, Carreira PE, Castellví I, Del Galdo F, Distler JHW, Foeldvari I, Fraticelli P, George PM, Griffiths B, Guillén-Del-Castillo A, Hamid AM, Horváth R, Hughes M, Kreuter M, Moazedi-Fuerst F, Olas J, Paul S, Rotondo C, Rubio-Rivas M, Seferian A, Tomčík M, Uzunhan Y, Walker UA, Więsik-Szewczyk E, Distler O (2020) The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements. Lancet Rheumatol 2(2):e71–e83. https://doi.org/10.1016/S2665-9913(19)30144-4

Article  CAS  PubMed  Google Scholar 

Lynch DA, Sverzellati N, Travis WD, Brown KK, Colby TV, Galvin JR, Goldin JG, Hansell DM, Inoue Y, Johkoh T, Nicholson AG, Knight SL, Raoof S, Richeldi L, Ryerson CJ, Ryu JH, Wells AU (2018) Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner society white paper. Lancet Respir Med 6(2):138–153. https://doi.org/10.1016/s2213-2600(17)30433-2

Article  PubMed  Google Scholar 

Travis WD, Costabel U, Hansell DM, King TE Jr., Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, Protzko S, Raghu G, Richeldi L, Sverzellati N, Swigris J, Valeyre D (2013) An official American thoracic society/european respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188(6):733–748. https://doi.org/10.1164/rccm.201308-1483ST

Article  PubMed  PubMed Central  Google Scholar 

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias (2002) This joint statement of the American thoracic society (ATS), and the European respiratory society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS executive committee. Am J Respir Crit Care Med 165(2):277–304. https://doi.org/10.1164/ajrccm.165.2.ats01

Article  Google Scholar 

Barnes H, Humphries SM, George PM, Assayag D, Glaspole I, Mackintosh JA, Corte TJ, Glassberg M, Johannson KA, Calandriello L, Felder F, Wells A, Walsh S (2023) Machine learning in radiology: the new frontier in interstitial lung diseases. Lancet Digit Health 5(1):e41–e50. https://doi.org/10.1016/s2589-7500(22)00230-8

Article  CAS  PubMed  Google Scholar 

Choe J, Hwang HJ, Lee SM, Yoon J, Kim N, Seo JB (2025) CT quantification of interstitial lung abnormality and interstitial lung disease: from technical challenges to future directions. Invest Radiol 60(1):43–52. https://doi.org/10.1097/rli.0000000000001103

Article  CAS  PubMed  Google Scholar 

Ohno Y, Aoyagi K, Takenaka D, Yoshikawa T, Fujisawa Y, Sugihara N, Hamabuchi N, Hanamatsu S, Obama Y, Ueda T, Hattori H, Murayama K, Toyama H (2022) Machine learning for lung texture analysis on thin-section CT: capability for assessments of disease severity and therapeutic effect for connective tissue disease patients in comparison with expert panel evaluations. Acta Radiol 63(10):1363–1373. https://doi.org/10.1177/02841851211044973

Article  PubMed  Google Scholar 

Su N, Hou F, Zhu H, Ma J, Liu F (2025) Assessing the severity of connective Tissue-Related interstitial lung disease using computed tomography quantitative analysis parameters. J Comput Assist Tomogr 49(3):448–455. https://doi.org/10.1097/rct.0000000000001693

Article  PubMed  Google Scholar 

Anthimopoulos M, Christodoulidis S, Ebner L, Christe A, Mougiakakou S (2016) Lung pattern classification for interstitial lung diseases using a deep convolutional neural network. IEEE Trans Med Imaging 35(5):1207–1216. https://doi.org/10.1109/tmi.2016.2535865

Article  PubMed  Google Scholar 

Gao M, Bagci U, Lu L, Wu A, Buty M, Shin HC, Roth H, Papadakis GZ, Depeursinge A, Summers RM, Xu Z, Mollura DJ (2018) Holistic classification of CT Attenuation patterns for interstitial lung diseases via deep convolutional neural networks. Comput Methods Biomech Biomed Eng Imaging Vis 6(1):1–6. https://doi.org/10.1080/21681163.2015.1124249

Article  PubMed  Google Scholar 

Hoffmann T, Teichgräber U, Lassen-Schmidt B, Renz D, Brüheim LB, Krämer M, Oelzner P, Böttcher J, Güttler F, Wolf G, Pfeil A (2024) Artificial intelligence-based quantification of pulmonary HRCT (AIqpHRCT) for the evaluation of interstitial lung disease in patients with inflammatory rheumatic diseases. Rheumatol Int. https://doi.org/10.1007/s00296-024-05715-0

Article  PubMed  PubMed Central  Google Scholar 

Handa T, Tanizawa K, Oguma T, Uozumi R, Watanabe K, Tanabe N, Niwamoto T, Shima H, Mori R, Nobashi TW, Sakamoto R, Kubo T, Kurosaki A, Kishi K, Nakamoto Y, Hirai T (2022) Novel artificial Intelligence-based technology for chest computed tomography analysis of idiopathic pulmonary fibrosis. Ann Am Thorac Soc 19(3):399–406. https://doi.org/10.1513/AnnalsATS.202101-044OC

Article  PubMed  Google Scholar 

Wu X, Yin C, Chen X, Zhang Y, Su Y, Shi J, Weng D, Jiang X, Zhang A, Zhang W, Li H (2022) Idiopathic pulmonary fibrosis mortality risk prediction based on artificial intelligence: the CTPF model. Front Pharmacol 13:878764. https://doi.org/10.3389/fphar.2022.878764

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao J, Long Y, Li S, Li X, Zhang Y, Hu J, Han L, Ren L (2024) Use of artificial intelligence algorithms to analyse systemic sclerosis-interstitial lung disease imaging features. Rheumatol Int 44(10):2027–2041. https://doi.org/10.1007/s00296-024-05681-7

Article  PubMed  PubMed Central  Google Scholar 

Guiot J, Henket M, Gester F, André B, Ernst B, Frix AN, Smeets D, Van Eyndhoven S, Antoniou K, Conemans L, Gote-Schniering J, Slabbynck H, Kreuter M, Sellares J, Tomos I, Yang G, Ribbens C, Louis R, Cottin V, Tomassetti S, Smith V, Walsh SLF (2025) Automated AI-based image analysis for quantification and prediction of interstitial lung disease in systemic sclerosis patients. Respir Res 26(1):39. https://doi.org/10.1186/s12931-025-03117-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johnson SR, Bernstein EJ, Bolster MB, Chung JH, Danoff SK, George MD, Khanna D, Guyatt G, Mirza RD, Aggarwal R, Allen A Jr., Assassi S, Buckley L, Chami HA, Corwin DS, Dellaripa PF, Domsic RT, Doyle TJ, Falardeau CM, Frech TM, Gibbons FK, Hinchcliff M, Johnson C, Kanne JP, Kim JS, Lim SY, Matson S, McMahan ZH, Merck SJ, Nesbitt K, Scholand MB, Shapiro L, Sharkey CD, Summer R, Varga J, Warrier A, Agarwal SK, Antin-Ozerkis D, Bemiss B, Chowdhary V, Dematte D, Amico JE, Hallowell R, Hinze AM, Injean PA, Jiwrajka N, Joerns EK, Lee JS, Makol A, McDermott GC, Natalini JG, Oldham JM, Saygin D, Lakin KS, Singh N, Solomon JJ, Sparks JA, Turgunbaev M, Vaseer S, Turner A, Uhl S, Ivlev I (2024) 2023 American college of rheumatology (ACR)/American college of chest physicians (CHEST) guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic diseases. Arthritis Care Res (Hoboken) 76(8):1070–1082. https://doi.org/10.1002/acr.25347